Evaluation of the antidepressant therapeutic potential of isocyanine and pseudoisocyanine analogues of the organic cation decynium-22

Simple item page
dc.contributor.authorKrause-Heuer, AMen_AU
dc.contributor.authorFraser-Spears, Ren_AU
dc.contributor.authorDobrowolski, JCen_AU
dc.contributor.authorAshford, MEen_AU
dc.contributor.authorWyatt, NAen_AU
dc.contributor.authorRoberts, MPen_AU
dc.contributor.authorGould, GGen_AU
dc.contributor.authorCheah, WCen_AU
dc.contributor.authorNg, CKLen_AU
dc.contributor.authorBhadbhade, MMen_AU
dc.contributor.authorZhang, Ben_AU
dc.contributor.authorGreguric, Ien_AU
dc.contributor.authorWheate, NJen_AU
dc.contributor.authorKumar, Nen_AU
dc.contributor.authorKoek, Wen_AU
dc.contributor.authorCallaghan, PDen_AU
dc.contributor.authorDaws, LCen_AU
dc.contributor.authorFraser, BHen_AU
dc.date.accessioned2021-08-11T06:13:47Zen_AU
dc.date.available2021-08-11T06:13:47Zen_AU
dc.date.issued2017-09-08en_AU
dc.date.statistics2021-08-10en_AU
dc.description.abstractAntidepressant-like activity Herein we describe the synthesis and evaluation of antidepressant properties of seven analogues (1–7) of the low affinity/high capacity transporter blocker decynium-22 (D-22). All analogues (1–7) were synthesized via base promoted coupling reactions between N-alkylated-2-methylquinolinium iodides or N-alkylated-4-methylquinolinium iodides and electrophilic N-alkylated-2-iodoquinolinium iodides. All final compounds were purified by re-crystallization or preparative HPLC and initial evaluation studies included; 1) screening for in vitro α1-adrenoceptor activity (a property that can lead to unwanted side-effects), 2) measuring antidepressant-like activity in a mouse tail suspension test (TST), and 3) measuring effects upon mouse locomotion. The results showed some analogues have lower affinities at α1-adrenoceptors compared to D-22 and showed antidepressant-like activity without the need for co-administration of SSRIs. Additionally, many analogues did not affect mouse locomotion to the same extent as D-22. Plans for additional evaluations of these promising analogues, including measurement of antidepressant-like activity with co-administration of selective serotonin re-uptake inhibitors (SSRIs), are outlined. © 2017 Elsevier B.V.en_AU
dc.identifier.citationKrause-Heuer, A. M., Fraser-Spears, R., Dobrowolski, J. C., Ashford, M. E., Wyatt, N. A., Roberts, M. P., Gould, G. G. Cheah, W-C., Ng, C. K. L., Bhadbhade, M., Zhang, B., Greguric, I., Wheate, N. J., Kumar, N. Koek, W., Callaghan, P. D., Daws, L. C., & Fraser, B. H. (2017). Evaluation of the antidepressant therapeutic potential of isocyanine and pseudoisocyanine analogues of the organic cation decynium-22. European Journal of Medicinal Chemistry, 137, 476-487. doi:10.1016/j.ejmech.2017.06.011en_AU
dc.identifier.issn0223-5234en_AU
dc.identifier.journaltitleEuropean Journal of Medicinal Chemistryen_AU
dc.identifier.pagination476-487en_AU
dc.identifier.urihttps://doi.org/10.1016/j.ejmech.2017.06.011en_AU
dc.identifier.urihttps://apo.ansto.gov.au/dspace/handle/10238/11330en_AU
dc.identifier.volume137en_AU
dc.language.isoenen_AU
dc.publisherElsevier B. V.en_AU
dc.subjectAntidepressantsen_AU
dc.subjectDrugsen_AU
dc.subjectCationsen_AU
dc.subjectIodidesen_AU
dc.subjectCrystallizationen_AU
dc.subjectSide effectsen_AU
dc.subjectDopamineen_AU
dc.titleEvaluation of the antidepressant therapeutic potential of isocyanine and pseudoisocyanine analogues of the organic cation decynium-22en_AU
dc.typeJournal Articleen_AU
Files
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.63 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Journal Articles